Misplaced Pages

Etiracetam

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by Beetstra (talk | contribs) at 17:16, 24 February 2007 (remove 'image = {{PAGENAME}}.png' from drugbox, see template talk:drugbox using AWB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 17:16, 24 February 2007 by Beetstra (talk | contribs) (remove 'image = {{PAGENAME}}.png' from drugbox, see template talk:drugbox using AWB)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound
Etiracetam
File:Etiracetam.png
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • Unscheduled (US)
Identifiers
IUPAC name
  • 2-(2-oxopyrrolidin-1-yl)butanamide
PubChem CID
CompTox Dashboard (EPA)
ECHA InfoCard100.111.445 Edit this at Wikidata
Chemical and physical data
FormulaC8H14N2O2
Molar mass170.209 g/mol g·mol
3D model (JSmol)
SMILES
  • CCC(C(=O)N)N1CCCC1=O

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active optical form is levetiracetam.

See also


Stub icon

This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it.

Categories:
Etiracetam Add topic